Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kiyohito Nakai
Observed names:
K. Nakai,
Kiyohito NAKAI
Institutions:
Ministry of Health Labour and Welfare,
Pharmaceuticals and Medical Devices Agency
Observed institutions:
Nihon University,
SHOWA Medical University,
Aoyama Gakuin University,
Ministry of Health Labour and Welfare,
Meiji Pharmaceutical University,
Pharmaceuticals and Medical Devices Agency
show all 6
ORCID:
0000-0002-6591-3201
Observed ORCID:
0000-0002-6591-3201
OpenAlex ID:
A5090185728
Safety monitoring of COVID-19 vaccines in Japan
2022
·
Toshihiro Yamaguchi
, Masao Iwagami
, et al.
·
The Lancet Regional Health - Western Pacific
·
35
PDF
The effect of one-dose package on medication adherence for the elderly care in Japan
2009
·
Kiyohito Nakai
, Nobuo Yamamoto
, et al.
·
Pharmacy Practice
·
24
PDF
International Harmonization of Bioequivalence Studies and Issues Shared in Common
2000
·
Kiyohito NAKAI
, Masahiko FUJITA
, et al.
·
YAKUGAKU ZASSHI
·
20
PDF
Development of Orphan Drugs in Japan: Effects of a Support System for Development of Orphan Drugs in Japan
2000
·
Makoto Shiragami
, Kiyohito Nakai
·
Drug Information Journal
·
17
Development of Orphan Drugs in Japan: Characteristics of Orphan Drugs Developed in Japan
2000
·
Makoto Shiragami
, Kiyohito Nakai
·
Drug Information Journal
·
11
New Japanese Regulatory Frameworks for Post-Marketing Management of Pharmaceutical Products
2020
·
Kento Takamura
, Keisuke Tachibana
, et al.
·
Pharmaceutical Research
·
10
A Review of the Regulatory Framework for Initiation and Acceleration of Patient Access to Innovative Medical Products in Japan
2019
·
Shunsuke Matsushita
, Keisuke Tachibana
, et al.
·
Clinical Pharmacology & Therapeutics
·
10
Introducing Internet Retailing of OTC Drugs in Japan: Revision of the Pharmaceutical Affairs Law
2014
·
Kiyohito Nakai
, Taihei Tanaka
·
Therapeutic Innovation & Regulatory Science
·
9
Updated report of COVID-19 vaccine safety monitoring in Japan: Booster shots and paediatric vaccinations
2022
·
Toshihiro Yamaguchi
, Masao Iwagami
, et al.
·
The Lancet Regional Health - Western Pacific
·
7
Legislation on the Roles of the Pharmacist and Pharmacy in the Revision of the Pharmaceutical and Medical Device Act and the Pharmacists Act in Japan
2020
·
Kento Takamura
, Keisuke Tachibana
, et al.
·
Therapeutic Innovation & Regulatory Science
·
7
Evaluation of new reimbursement fee for care of pharmacists in Japan
2018
·
Kiyohito Nakai
·
Pharmacy & Pharmacology International Journal
·
7
PDF
Role of US Pharmacists in Medication Therapy Management-Situation of Collaborative Drug Therapy Management (CDTM)-
2011
·
Kiyohito Nakai
, Atsushi Kawahara
·
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
·
5
PDF
The equine antitoxins supply system for biological poisons in Japan
2003
·
Kiyohito Nakai
, Motohide Takahashi
, et al.
·
Toxicon
·
5
New Bioequivalence Studies : Individual Bioequivalence and Population Bioequivalence
2000
·
Kiyohito NAKAI
, Masahiko FUJITA
, et al.
·
YAKUGAKU ZASSHI
·
5
PDF
Comparison of average and population bioequivalence approach
2002
·
K. Nakai
, M. Fujita
, et al.
·
International Journal of Clinical Pharmacology and Therapeutics
·
4
Japanese Regulation on GMP/GQP and Its Challenges
2009
·
Kiyohito Nakai
, Hirotada Nagai
, et al.
·
Journal of Pharmaceutical Innovation
·
3
Electronic Common Technical Document Implementation in Japan
2009
·
Kiyohito Nakai
, Yasuhiro Araki
, et al.
·
Drug Information Journal
·
3
Japan’s Pharmaceutical Regulatory Reform to Overcome Drug Loss Issue
2026
·
Kiyohito Nakai
·
Therapeutic Innovation & Regulatory Science
·
2
Updated report of COVID-19 vaccine safety monitoring in Japan: booster doses for Omicron variants and vaccinations for infants and young children
2023
·
Toshihiro Yamaguchi
, Masao Iwagami
, et al.
·
The Lancet Regional Health - Western Pacific
·
2
PDF
New role of Japanese pharmacists focusing on medication therapy management in a team care approach
2020
·
Atsushi Kawahara
, Kiyohito Nakai
, et al.
·
Journal of Pharmacy Practice and Research
·
2
PDF
Litigation Risks on Conducting CDMT in the US: Based on Cases of Nurse Practitioners
2015
·
Atsushi Kawahara
, Kiyohito Nakai
, et al.
·
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
·
1
PDF
The Effect of the Orphan Drug Development Support Program.
1999
·
Makoto SHIRAGAMI
, Kiyohito NAKAI
·
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
·
1
PDF
Analysis of Orphan Drug Development in Japan.
1999
·
Makoto SHIRAGAMI
, Kiyohito NAKAI
·
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
·
1
PDF
Provision of Drug Information Using Database Surveys-Enhancing Clinical Information for Patients with Specific Backgrounds
2024
·
Kiyohito Nakai
, Mie Ikeda
, et al.
·
Therapeutic Innovation & Regulatory Science
Japan: Ministry of Health, Labour and Welfare and Pharmaceutical Administration
2018
·
Kiyohito Nakai
Show more works
View as search
Works count:
32
Citation count:
192
H-index:
8
I10-index:
7
Year
Topic
Type